CoChat

A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action

Open access
Yuan, Kai, Zheng, Yong-Bo, Wang, Yi-Jie, Sun, Yan-Kun, Gong, Yi-Miao, Huang, Yue-Tong, Chen, Xuan, Liu, Xiao-Xing, Zhong, Yi, Su, Si-Zhen, Gao, Nan, Lu, Yi-Long, Wang, Zhe, Liu, Wei-Jian, Que, Jian-Yu, Yang, Ying-Bo, Zhang, An-Yi, Jing, Meng-Ni, Yuan, Chen-Wei, Zeng, Na, Vitiello, Michael V, Patel, Vikram, Fazel, Seena, Minas, Harry, Thornicroft, Graham, Fan, Teng-Teng, Lin, Xiao, Yan, Wei, Shi, Le, Shi, Jie, Kosten, Thomas, Bao, Yan-Ping, Lu, Lin · 2022 · Molecular Psychiatry
Cited by 204

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Infectious disease epidemics have become more frequent and more complex during the 21st century, posing a health threat to the general public and leading to psychological symptoms. The current study was designed to investigate the prevalence of and risk factors associated with depression, anxiety and insomnia symptoms during epidemic outbreaks, including COVID-19. We systematically searched the PubMed, Embase, Web of Science, OVID, Medline, Cochrane databases, bioRxiv and medRxiv to identify studies that reported the prevalence of depression, anxiety or insomnia during infectious disease epidemics, up to August 14th, 2020. Prevalence of mental symptoms among different populations including the general public, health workers, university students, older adults, infected patients, survivors of infection, and pregnant women across all types of epidemics was pooled. In addition, prevalence of mental symptoms during COVID-19 was estimated by time using meta-regression analysis. A total of 17,506 papers were initially retrieved, and a final of 283 studies met the inclusion criteria, representing a total of 948,882 individuals. The pooled prevalence of depression ranged from 23.1%, 95% confidential intervals (95% CI: [13.9–32.2]) in survivors to 43.3% (95% CI: [27.1–59.6]) in university students, the pooled prevalence of anxiety ranged from 25.0% (95% CI: [12.0–38.0]) in older adults to 43.3% (95% CI: [23.3–63.3]) in pregnant women, and insomnia symptoms ranged from 29.7% (95% CI: [24.4–34.9]) in the general public to 58.4% (95% CI: [28.1–88.6]) in university students. Prevalence of moderate-to-severe mental symptoms was lower but had substantial variation across different populations. The prevalence of mental problems increased over time during the COVID-19 pandemic among the general public, health workers and university students, and decreased among infected patients. Factors associated with increased prevalence for all three mental health symptoms included female sex, and having physical disorders, psychiatric disorders, COVID infection, colleagues or family members infected, experience of frontline work, close contact with infected patients, high exposure risk, quarantine experience and high concern about epidemics. Frequent exercise and good social support were associated with lower risk for these three mental symptoms. In conclusion, mental symptoms are common during epidemics with substantial variation across populations. The population-specific psychological crisis management are needed to decrease the burden of psychological problem and improve the mental wellbeing during epidemic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-022-01638-z

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 204

Metadata

Authors
Yuan, K., Zheng, Y.-B., Wang, Y.-J., Sun, Y.-K., Gong, Y.-M., Huang, Y.-T., Chen, X., Liu, X.-X., Zhong, Y., Su, S.-Z., Gao, N., Lu, Y.-L., Wang, Z., Liu, W.-J., Que, J.-Y., Yang, Y.-B., Zhang, A.-Y., Jing, M.-N., Yuan, C.-W., Zeng, N., Vitiello, M. V., Patel, V., Fazel, S., Minas, H., Thornicroft, G., Fan, T.-T., Lin, X., Yan, W., Shi, L., Shi, J., Kosten, T., Bao, Y.-P., & Lu, L.
Venue
Molecular Psychiatry
Published
2022-06-06
Volume
27
Issue
8
Pages
3214-3222
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W4281648256
Cited by
204
References
27
FWCI
8.39
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. https://app.cochat.ai/papers/10.1038/s41380-022-01638-z
The paper
Yuan, K., Zheng, Y.-B., Wang, Y.-J., Sun, Y.-K., Gong, Y.-M., Huang, Y.-T., Chen, X., Liu, X.-X., Zhong, Y., Su, S.-Z., Gao, N., Lu, Y.-L., Wang, Z., Liu, W.-J., Que, J.-Y., Yang, Y.-B., Zhang, A.-Y., Jing, M.-N., Yuan, C.-W., . . . Lu, L. (2022). A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01638-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.